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SUMMARY
Aortic Valve Stenosis (AVS) has been explained as an atherosclerotic process of the valve as they often exhibit inflammatory
changes with infiltration of macrophages, T lymphocytes and lipid infiltration. The present study investigated whether the bacteria
Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP), detected previously in atherosclerotic plaques, are also present in
AVS. Ten valves surgically removed from patients with AVS were analyzed by immunohistochemistry, in situ hybridization, and
electron microscopy. The mean and standard deviation of the percentage areas occupied by CP antigens and MP - DNA were respectively
6.21 +/- 5.41 and 2.27 +/- 2.06 in calcified foci; 2.8 +/- 3.33 and 1.78+/- 3.63 in surrounding fibrotic areas, and 0.21 +/- 0.17 and 0.12
+/- 0.13 in less injured parts of the valve. There was higher amount of CP and MP in the calcified foci and in the surrounded fibrosis
than in more preserved valvular regions. In conclusion, the fact that there were greater amounts of CP and MP in calcification foci of
AVS favors the hypothesis that AS is not an inevitable degenerative process due to aging, but rather that it may be a response to the
presence of these bacteria, similarly to the morphology detected in atherosclerosis damage.
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INTRODUCTION
Age-related degenerative calcified aortic valve stenosis is now the
most frequent cause of AVS in adults, frequently requiring aortic valve
replacement13. It is usually considered to result from years of normal
mechanical stress on a valve. Some studies have suggested that it would
be similar a process to arterial atherosclerosis, as these valves often exhibit
infiltration of macrophages and T lymphocytes nearby the calcified
nodules12,14. Hypercholesterolemia seems to accelerate age-related
degenerative changes in the aortic root and valve15, and traditional risk
factors for atherosclerosis such as cigarette smoking, history of
hypertension, and low high-density-lipoprotein (HDL) cholesterol values
are also related to calcified AVS18.
Chlamydia pneumoniae (CP) seems to be involved in atherosclerotic
process pathogenesis4,19. This bacterium has also been detected in vascular
tissues and degenerative heart valves4,9.
Recent studies from our Lab have detected large amounts of
Mycoplasma pneumoniae (MP) and CP in ruptured coronary
atherosclerotic plaques, which were also accompanied by increased
number of lymphocytes6,7,8. The present study investigated whether MP
and CP were present in AVS valves, in association with calcification
foci and inflammation, as noticed in atherosclerotic plaques.
MATERIALS AND METHODS
Ten aortic valves surgically removed from AS patients, fixed in 10%
formalin, decalcified in formic acid 25% and embedded in paraffin were
sectioned in 5 µm slices and submitted to immunohistochemical (IHC)
technique for detection of CP and in situ hybridization technique for
detection of MP and CP. Representative transversal sections of the most
calcified cuspid were analyzed, separated in three different regions: A)
Calcified nodules, B) Fibrosis surrounding the calcified nodules, and C)
Most preserved region of the valve.
Quantification of CP antigens and MP DNA was performed with
image analysis system Quantimet 500 - Leica, using 20x magnification
objective. All fields presented in the section were analyzed. It was
obtained mean values of % area of CP antigens and % area of MP DNA
/ 200x microscopic field.
Representative fragments were also collected for electron microscopy
analysis.
For immunohistochemistry the slides were incubated with pure
monoclonal anti-CP antibody (clone RR-402, Dako, Carpinteria, CA,
USA, anti-major outer external membrane of CP), according to previously
described technique6.
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For in situ hybridization, it was used the technique described in a previous
paper7 and summarized below. For MP DNA detection the slides were incubated
with 20 µl of hybridization mixture containing the probe prepared from a
highly specific MP clone (Enzo Diagnosis, Farmingdale, NY, USA). For
detection of CP DNA the probe was the biotinylated labeled CP oligonucleotide
synthesise by GIBCO/ BRL, Rockville, MD, USA. The signal was amplified
using the catalyzed signal amplification system for ISH, Dakogen Point (Dako,
Carpinteria, CA, USA). The reaction was visualized with the chromogen 3,3-
diaminobenzidine (Dako, Carpinteria, CA, USA).
Positive controls of immunohistochemistry and in situ hybridization
techniques were performed using rats and rabbits respectively infected
with Chlamydia pneumoniae and Mycoplasma pneumoniae. These
animals had positive diagnosis of these infectious agents by culture.
For electron microscopy, the tissue was decalcified in tri-chloroacetic
acid 5%, fixed in 3% glutaraldehyde 0.1M, post-fixed with 1% osmium
tetroxide and blocked in araldite resin17.
Figs. 1A, 1B and 1C - Histological sections of aortic valves immunostained against C. pneumoniae antigens (arrows). Antigens were concentrated into the calcified nodules (*) and in the
surrounding fibrotic tissue (1A - 20X). In higher power view antigens in brown colour are seen in the cytoplasm of macrophages, lymphocytes and extracellular matrix surrounding the calcified
foccus (1B - 40X), and in the necrotic center of the calcified nodules (1C - 40X). Fig. 1D - CP-DNA (arrow) in the necrotic center of a calcified area (ISH - 40X). Figs. 1E and 1F show M.
pneumoniae-DNA (arrows), detected by ISH, in calcified foci, usually abundant (1E - 40X) but scarce in old foci (1F - 20X).
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RESULTS
CP antigens were present in the calcified nodules and in their
surrounded fibrotic tissue in a diffuse and homogeneous pattern (Fig.
1A). In the periphery of these nodules, there was moderate to severe
inflammatory infiltrate with several macrophages containing positive
granules (brown color) or homogeneous pattern in the cytoplasm or as
positive dots in the extracellular matrix (Fig. 1B). Dots were also seen
in calcified nodules (Fig. 1C). The in situ hybridization technique
demonstrated CP-DNA mainly at the periphery of the calcified foci (Fig.
1D). The mean and standard deviations of CP antigens percentage areas
were 6.21 ± 5.41 in calcified areas; 2.8 ± 3.33 in surrounding fibrotic
areas; and 0.21 ± 0.17 in preserved areas.
MP-DNA was seen as brown dots concentrated in the calcified foci,
mainly in those surrounded by inflammatory infiltrate (Fig. 1E). Older
calcified foci, which were characterized as surrounded by dense acellular
fibrosis without inflammatory infiltrate, were almost negative for MP-
DNA (Fig. 1F). The mean % areas of MP-DNA were 2.27 ± 2.06 in
calcified areas; 1.78 ± 3.3 in fibrotic areas; and 0.12 ± 0.13 in preserved
areas of the valve.
There was a significantly higher amount of MP and CP in the calcified
nodules than in more preserved areas (Student T paired test = p < 0.05).
CP antigen concentration in the calcified nodules was also significantly
higher than in the fibrotic surrounding tissue (p < 0.05).
Electron microscopy also demonstrated great amount of round small
structures compatible with bacteria in the calcified areas. Most of them were
dark, round, involved by two membranes, frequently exhibiting an expansion
of the external membrane, characterizing CP elementary bodies (Fig. 2A); as
their limits and membranes were not very well defined, they were considered
as degradation of the bacteria. Less electron-dense granulous and rounded
elements, involved by a membrane compatible with mycoplasma, were detected
in smaller amounts (Fig. 2A). In the tissues adjacent to the calcified foci, the
bacteria had better preserved membranes. Many empty membranous structures
suggestive of bacteria debris (Fig. 2B) were seen.
DISCUSSION
Some similarities between atherosclerosis of the valve and AVS, such
as chronic inflammation with macrophages and T lymphocytes, have
been described10,11,12. In the present study, it was observed that calcified
nodules of AS valves present high concentration of CP and MP, detected
by in situ hybridization, immunohistochemistry and electron microscopy.
The fibrotic tissue surrounding the calcified foci presented high amount
of CP antigens. Culture for detection of mycoplasmas was not used
because these are bacteria that grow very well when in contact with host
cells, but hardly ever grow in culture media. Mycoplasmas are the smallest
and simplest self-replicating bacteria and the only bacteria that use
cholesterol for proliferation. Macrophage activation, cytokine induction
and superantigen formation are properties related with the pathogenicity
of mycoplasma and they increase virulence of other contiguous infectious
agents16.
Dystrophic calcification is found in foci of enzymatic necrosis of
fat. Calcification is present in most advanced atheromas and damaged
ageing heart valves. The presence of great amount of membrane
degenerated CP and MP is the appropriate substrate to favor deposition
of calcium.
Extracellular dystrophic calcification occurs in the presence of
phospholipids found in 200-m membrane-bound vesicles in the cartilage
and bone and in pathologic calcification. Calcification has several steps:
(1) Calcium ion binds to the phospholipids of the vesicle membranes; (2)
membrane phosphatase generates phosphate groups, which bind to calcium;
(3) the binding cycle of calcium and phosphatase is repeated, producing a
deposit near the membrane; and (4) a structural change occurs in the
arrangement of calcium and phosphate groups generating a microcrystal,
which can then propagate and perforate the membrane3. CP actively
participates in the destruction of the extracellular matrix, by regulating
the expression of some enzymes such as 92-kDa gelatinase by
macrophages20. The results of the present study may indicate that calcified
foci in AVS represent severe proliferation of MP and CP and the fibrosis
surrounding them could be a host defense response to circumscribe these
infectious agents. It is not expectable to find great amounts of mycoplasmas
amidst fibrosis, as they do not survive among dense hard collagen because
of lack cholesterol. Some CP may survive, because as it was already
mentioned, they can digest the extracellular matrix. Differently from other
bacteria that usually cause acute infectious endocarditis inciting
neutrophilic inflammation, the present bacteria cause insidious, chronic
inflammation that culminates with fibrosis and calcification of the valves.
Recent data pointed to an association between AVS and systemic
atherosclerosis and inflammation. These include association with
symptomatic peripheral arterial disease in the elderly1, coronary artery
disease2 and increased C-reactive protein5. In our view, AVS could be a
sequel of a chronic infectious injury, which is in accordance with the
findings just described.
Further studies analyzing the occurrence of these bacteria in non-
calcified valves are necessary in order to better clarify why these bacteria
proliferate only in some patients, leading to development of AVS.
In conclusion, calcification foci in AVS contain large amounts of
mostly degenerated Chlamydia pneumoniae and Mycoplasma
pneumoniae bacteria. This finding suggests that AVS is not an inevitable
degenerative process due to ageing, but rather that it may be a response
to the presence of these bacteria, whose morphology is similar to that of
atherosclerosis damage.
RESUMO
Mycoplasma pneumoniae e Chlamydia pneumoniae nos focos de
calcificação de valva aórtica estenótica
Estenose da Valva Aórtica (EVA) tem sido considerada como um
processo aterosclerótico das valvas pois elas freqüentemente exibem
alterações inflamatórias com acúmulo de macrófagos e linfócitos T, bem
como infiltração de lípides. O presente estudo investigou se as bactérias
Chlamydia pneumoniae (CP) e Mycoplasma pneumoniae (MP),
detectadas previamente em placas ateroscleróticas, estavam presentes
na EVA.  Dez valvas removidas cirúrgicamente de pacientes com EVA
foram analisadas pela imunohistoquímica, hibridização in situ e
microscopia eletrônica. A média e desvio padrão das porcentagens de
área ocupadas por antígenos de CP e de DNA do MP foram

HIGUCHI, M.L.; HIGUCHI-DOS-SANTOS, M.H.; PIERRI, H.; PALOMINO, S.; SAMBIASE, N.V.; RAMIRES, J.A.F. & WAJNGARTEN, M. - Mycoplasma pneumoniae and Chlamydia
pneumoniae in calcified nodules of aortic stenotic valves. Rev. Inst. Med. trop. S. Paulo, 44(4):209-212, 2002.
respectivamente de 6,21 +/- 5,41 e 2,27 +/- 2,06  nos focos de calcificação;
2,8 +/- 3,33 e 1,78+/- 3,063 nas áreas de fibrose ao redor e 0,21 +/- 0,17
e 0,12 +/- 0,13 nas regiões menos lesadas da válvula. Houve uma maior
quantidade de CP e MP nos focos de calcificação e na fibrose ao redor
do que nas regiões valvulares mais preservadas. Em conclusão, o fato de
haver maior quantidade de CP e MP nos focos de calcificação da EVA
favorece a hipótese de que a estenose aórtica não é um processo
degenerativo inevitável devido a idade, mas sim uma resposta inflamatória
à presença dessas bactérias, em uma morfologia semelhante à detectada
na injúria aterosclerótica.
ACKNOWLEDGMENT
This study was financially supported by FAPESP (Project No. 99/
00322-9 and 00/06974-7).
REFERENCES
1. ARONOW, W. S.; AHN, C. & KRONZON, I. - Association of valvular aortic stenosis
with symptomatic peripheral arterial disease in older persons. Amer. J. Cardiol., 88:
1046-1047, 2001.
2. AVAKIAN, S.D.; GRINBERG, M.; MENEGUETTI, J.C.; RAMIRES, J.A. & MANSUR,
A.P. - SPECT dipyridamole scintigraphy for detecting coronary artery disease in
patients with isolated severe aortic stenosis. Int. J. Cardiol., 81: 21-27, 2001.
3. COTRAN, R.S.; KUMAR, V. & COLLINS, T. - Cellular Pathology. II: adaptations,
intracellular accumulations, and cell aging. In: COTRAN, R.S.; KUMAR, V. &
COLLINS, T., ed. Robbins pathologic basis of disease. 6. ed. Philadelphia, W.B.
Saunders, 1999. p. 43-44.
4. DANESH, J.; COLLINS, R. & PETO, R. - Chronic infections and coronary heart disease:
is there a link? Lancet, 350: 430-436, 1997.
5. GALANTE, A.; PIETROIUSTI, A.; VELLINI, M. et al. - C-reactive protein is increased
in patients with degenerative aortic valvular stenosis. J. Amer. Coll. Cardiol., 142:
725-732, 2001.
6. HIGUCHI, M.L.; CASTELLI, J.B.; AIELLO, V.D. et al. - Great amount of Chlamydia
pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study of
stable plaques. Arq. bras. Cardiol., 74: 149-151, 2000.
7. HIGUCHI, M.L.; SAMBIASE, N.; PALOMINO, S. et al. - Detection of Mycoplasma
pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz.
J. med. biol. Res., 33: 1023-1026, 2000.
8. HIGUCHI, M.L.; GUTIERREZ, P.S.; BEZERRA, H.G. et al. - Comparison between
adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic
plaques in human coronary arteries. Arq. bras. Cardiol., 79: 20-24, 2002.
9. JUVONEN, J.; LAURILA, A.; JUVONEN, T. et al. - Detection of Chlamydia pneumoniae
in human nonrheumatic stenotic aortic valves. J. Amer. Coll. Cardiol., 29: 1054-
1059, 1997.
10. OLSSON, M.; DALSGAARD, C.J.; HAEGERSTRAND, A. et al. - Accumulation of T
lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic
valves. J. Amer. Coll. Cardiol., 23: 1162-1170, 1994.
11. OLSSON, M.; ROSENQVIST, M. & NILSSON, J. - Expression of HLA-DR antigen
and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative
aortic stenosis. J. Amer. Coll. Cardiol., 24: 1664-1671, 1994.
12. OTTO, C.M.; KUUSISTO, J.; REICHENBACH, D.D.; GOWN, A.M. & O’BRIAN,
K.D. - Characterization of the early lesion of ‘degenerative’ aortic stenosis.
Histological and immunohistochemical studies. Circulation, 90: 844-853, 1994.
13. OTTO, C.M.; LIND, B.K.; KITZMAN, D.W.; GERSH, B.J. & SISCOVICK, D.S. -
Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in
the elderly. New Engl. J. Med., 341: 142, 1999.
14. POHLE, K.; MÄFFERT, R.; ROPERS, D. et al. - Progression of aortic valve calcification:
association with coronary atherosclerosis and cardiovascular risk factors. Circulation,
104: 1927-1932, 2001.
15. RALLIDIS, L.; NAOUMOVA, R.P.; THOMPSON, G.R. & NIHOYANNOPOULOS, P.
- Extent and severity of atherosclerotic involvement of the aortic valve and root in
familial hypercholesterolaemia. Heart, 80: 583-590, 1998.
16. RAZIN, S.; YOGEV, D. & NAYOT, Y. - Molecular biology and pathogenicity of
mycoplasmas. Microbiol. molec. Biol. Rev., 62:1094-1156, 1998.
17. REYNOLDS, E. S. - The use of lead citrate at high pH as an electron-opaque stain in
electron microscope. J. Cell Biol., 17: 208-212, 1963.
18. STEWART, B.F.; SISCOVICK, D.; LIND, B.K. et al - Clinical factors associated with
calcified aortic valve disease. J. Amer. Coll. Cardiol., 29: 630-634, 1997.
19. TAYLOR-ROBINSON, D. & THOMAS, B.J. - Chlamydia pneumoniae in arteries: the
facts, their interpretation, and studies. J. clin. Path., 51: 793-797, 1998.
20. VEHMAAN-KREULA, P.; PUOLAKKAINEN, M.; SARVAS, M. et al. - Chlamydia
pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte-
derived macrophages. Arterioscler. Thromb. vasc. Biol., 21: E1-E8, 2001.
Received: 13 May 2002
Accepted: 28 June 2002
Figs. 2A and 2B - Electron microscopic views of aortic stenotic valve. Fig. 2A shows great
amount of CP - Chlamydia pneumoniae elementary bodies with the characteristic “pear shape” and
MP - Mycoplasma pneumoniae - involved by one membrane, in a focus of calcification (- 13,000 X
- original magnification). Fig. 2B demonstrates MP and CP with better preserved membranes
among the inflammatory infiltrate adjacent the calcification (7,200 X - original magnification).
